-transparent.png){kind=logo}
Three cases of heparin induced thrombotic thrombocytopenia are reported. Pathogenesis, clinical and biological manifestations as well as treatment are reviewed. Treatment consisted in replacing the heparin by a vitamin K antagonist or a low molecular weight heparin. During heparin treatment, the risk of thrombotic thrombocytopenia should be kept in mind and the platelet count monitored from time to time.
Related Publications
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
March 1984,
Annales de chirurgie,
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
January 1984,
Annales de cardiologie et d'angeiologie,
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
December 1984,
LARC medical,
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
January 1985,
Phlebologie,
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
January 1993,
Annales francaises d'anesthesie et de reanimation,
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
January 1988,
Deutsche medizinische Wochenschrift (1946),
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
January 1987,
Deutsche medizinische Wochenschrift (1946),
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
January 1999,
Annales de cardiologie et d'angeiologie,
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
January 1987,
Cahiers d'anesthesiologie,
C Homareau, and
B Le Guyader, and
J F Roche, and
H Ronsse, and
C Rouet
February 1991,
Revue medicale de Liege,
